Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 201 - 225 of 3913 in total
Main Class Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ▲ ChEBI ID Exact Mass Formula
Neutral glycosphingolipids Simple Glc series LMSP0501AD03
  • Manbeta1-4Glcbeta-Cer(d18:1/20:0)
44260158 917.680344 C50H95NO13
Neutral glycosphingolipids Simple Glc series LMSP0501AD04
  • Manbeta1-4Glcbeta-Cer(d18:1/22:0)
44260159 945.711644 C52H99NO13
Neutral glycosphingolipids Simple Glc series LMSP0501AD05
  • Manbeta1-4Glcbeta-Cer(d18:1/24:0)
44260160 973.742944 C54H103NO13
Neutral glycosphingolipids Simple Glc series LMSP0501AD06
  • Manbeta1-4Glcbeta-Cer(d18:1/26:0)
44260161 1001.774244 C56H107NO13
Neutral glycosphingolipids Simple Glc series LMSP0501AD07
  • Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260162 971.727294 C54H101NO13
Neutral glycosphingolipids Simple Glc series LMSP0501AD08
  • Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260163 999.758594 C56H105NO13
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA01
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Gb3(d18:1/16:0)
44260164 84687 1023.670569 C52H97NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA02
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • Gb3(d18:1/18:0)
44260165 84690 1051.701869 C54H101NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA03
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • Gb3(d18:1/20:0)
44260166 84692 1079.733169 C56H105NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA04
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Gb3(d18:1/22:0)
44260167 84694 1107.764469 C58H109NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA05
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Gb3(d18:1/24:0)
44260168 84695 1135.795769 C60H113NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA06
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Gb3(d18:1/26:0)
44260169 75188 1163.827069 C62H117NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA07
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Gb3(d18:1/24:1(15Z))
44260170 84696 1133.780119 C60H111NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA08
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Gb3(d18:1/26:1(17Z))
44260171 133816 1161.811419 C62H115NO18
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB01
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Globoside I/Cytolipin K(d18:1/16:0)
44260172 132968 1226.749943 C60H110N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB02
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • Globoside I/Cytolipin K(d18:1/18:0)
44260173 52988 1254.781243 C62H114N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB03
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • Globoside I/Cytolipin K(d18:1/20:0)
44260174 1282.812543 C64H118N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB04
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Globoside I/Cytolipin K(d18:1/22:0)
44260175 1310.843843 C66H122N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB05
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Globoside I/Cytolipin K(d18:1/24:0)
44260176 1338.875143 C68H126N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB06
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Globoside I/Cytolipin K(d18:1/26:0)
44260177 1366.906443 C70H130N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB07
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Globoside I/Cytolipin K(d18:1/24:1(15Z))
44260178 84125 1336.859493 C68H124N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB08
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Globoside I/Cytolipin K(d18:1/26:1(17Z))
44260179 1364.890793 C70H128N2O23
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC01
  • Forssman antigen(d18:1/16:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260180 1429.829317 C68H123N3O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC02
  • Forssman antigen(d18:1/18:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260181 1457.860617 C70H127N3O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC03
  • Forssman antigen(d18:1/20:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260182 1485.891917 C72H131N3O28

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024